A new national study, including researchers from the Faculty of Medicine, will work to identify accurate and quick blood tests that can diagnose dementia.

The aim of the the Blood Biomarker Challenge is to revolutionise dementia diagnosis and improve the UK’s diagnosis rate. It is being led by University College London, and Dementias Platform UK and will be based at the University of Oxford.

Southampton will be one of the recruitment centres. Patients will be part of either the READ-OUT study, which will test multiple existing and novel blood tests, looking at a range of types of dementia, including Alzheimer’s disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies; or the ADAPT study, which will focus on the most promising biomarker for Alzheimer’s disease, called p-tau217.

Find the full story here.